FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

20449611000001108: Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral suspension (Drug Tariff Special Order) (product)


Status: current, Not sufficiently defined by necessary conditions definition status. Date: 30-May 2012. Module: SNOMED CT United Kingdom drug extension module

Descriptions:

Id Description Lang Type Status Case? Module
68978701000001119 Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral suspension (Drug Tariff Special Order) (product) en Fully specified name Active Entire term case sensitive SNOMED CT United Kingdom drug extension module
104508701000001119 Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral suspension (Special Order) en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom drug extension module


0 descendants.

Expanded Value Set


Outbound Relationships Type Target Active Characteristic Refinability Group Values
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral suspension (Drug Tariff Special Order) Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral suspension (Drug Tariff Special Order) Has NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction indicator NHS dm+d (dictionary of medicines and devices) AMP (actual medicinal product) availability restriction special true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral suspension (Drug Tariff Special Order) Is a Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral suspension true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral suspension (Drug Tariff Special Order) Has active ingredient Magnesium glycerophosphate true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral suspension (Drug Tariff Special Order) VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral suspension (Drug Tariff Special Order) VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral suspension (Drug Tariff Special Order) Has specific active ingredient Magnesium glycerophosphate true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral suspension (Drug Tariff Special Order) Has dispensed dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral suspension (Drug Tariff Special Order) Has NHS dm+d (dictionary of medicines and devices) basis of strength substance Magnesium true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral suspension (Drug Tariff Special Order) Has excipient Excipient not declared true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral suspension (Drug Tariff Special Order) Is a Actual medicinal product true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral suspension (Drug Tariff Special Order) Has manufactured dose form Conventional release oral suspension true Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral suspension (Drug Tariff Special Order) Has basis of strength substance Magnesium true Inferred relationship Existential restriction modifier

Inbound Relationships Type Active Source Characteristic Refinability Group
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral suspension (Drug Tariff Special Order) 1 ml Has AMP True Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral suspension (Drug Tariff Special Order) Inferred relationship Existential restriction modifier
Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral suspension (Drug Tariff Special Order) 150 ml Has AMP True Magnesium glycerophosphate (magnesium 121.25mg/5ml (5mmol/5ml)) oral suspension (Drug Tariff Special Order) Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start